---
id: antimalarial-primaquine-contraindications_256
category: antimicrobials
tags: [antimalarials, primaquine, tafenoquine, G6PD, contraindications]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Primaquine/Tafenoquine: Indications and Contraindications

**Q:** What are the indications for primaquine/tafenoquine in malaria treatment, and what are the absolute contraindications? (Use mnemonic **PG PreG**)

**A:**

**Indications:**
1. **Hypnozoite eradication** (*P. vivax, P. ovale*) - prevents relapse
2. **Terminal prophylaxis** after *P. vivax/ovale* exposure
3. **Gametocytocidal** (*P. falciparum*) - blocks transmission

**Dosing:**
- **Primaquine**: 30 mg base PO daily × 14 days (adjust for ≥70 kg: 6 mg/kg total)
- **Tafenoquine**: Single 300 mg dose (age ≥16 years)

**PG PreG Contraindications:**
- **P**regnancy (absolute contraindication - hemolytic risk to fetus)
- **G**6PD deficiency (hemolytic anemia - requires **quantitative** G6PD testing before use)
- **Pre**mature infants/neonates (avoid)
- **G**estation (breastfeeding if infant G6PD-deficient)

**Additional:** Tafenoquine also contraindicated <16 years old.

**Key Pearl:** Chloroquine-resistant *P. vivax* found in Papua New Guinea and Indonesia.

**Media:**

**Sources:** [CDC Malaria Treatment Guidelines 2024], [CDC Treatment of Uncomplicated Malaria], [StatPearls Primaquine]
